Evidence map›Paper›PMID 35125833›Full record

ArticleWorld journal of gastroenterology2022

Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?

Semra Demirli Atici, Erdinc Kamer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Semra Demirli AticiDepartment of General Surgery, University of Health Sciences Tepecik Training and Research Hospital, İzmir 35180, Turkey. smrdemirli@hotmail.com.
Erdinc KamerDepartment of General Surgery, University of Health Sciences Tepecik Training and Research Hospital, İzmir 35180, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evaluation of response to chemotherapy in colorectal cancer patients with synchronous liver metastases is important in terms of treatment management. In this Letter to the Editor, several issues in the article are discussed. For the comparison of carbohydrate antigen 19-9 (CA19-9) values referenced in the study, the patient group was not matched for cancer stage. Therefore, it may be more appropriate to select and compare CA19-9 values in patients with same-stage cancer.

Indexed as

Colorectal NeoplasmsLiver NeoplasmsCA-19-9 AntigenHumansNeoplasm StagingCA-19-9 AntigenCarbohydrate antigen 19-9ChemotherapyColorectal cancerLiver metastasis of colorectal cancerMetastatic colorectal cancerSynchronous liver metastasis

Identifiers

PMID35125833
PMCPMC8790559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.